CB10-277

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 206061

CAS#: 7203-91-0

Description: CB10-277 is a synthetic derivative of dimethylphenyl-triazene related to dacarbazine, with antineoplastic properties. Related to the agent dacarbazine, CB10-277 is converted in vivo to a monomethyl triazene form that alkylates DNA, resulting in inhibition of DNA replication and repair; in addition, this agent may act as a purine analogue, resulting in inhibition of DNA synthesis, and may interact with protein sulfhydryl groups.

Chemical Structure

img
CB10-277
CAS# 7203-91-0
Handing Instruction

Theoretical Analysis

MedKoo Cat#: 206061
Name: CB10-277
CAS#: 7203-91-0
Chemical Formula: C9H11N3O2
Exact Mass: 193.08513
Molecular Weight: 193.2
Elemental Analysis: C, 55.95; H, 5.74; N, 21.75; O, 16.56

Size Price Shipping out time Quantity
Inquire bulk and customized quantity
Pricing updated 2021-02-28. Prices are subject to change without notice.

CB10-277 is not in stock, may be available through custom synthesis. For cost-effective reason, minimum 1 gram order is requested. The product will be characterized by NMR, HPLC and MS analysis. Purity (HPLC) is usually >98%. CoA, QC data, MSDS will be provided when product is successfully made. The estimated lead time is 2-3 months. Please send email to sales@medkoo.com to inquire quote.

Synonym: CB10277; CB10-277; CB10 277; 1pcarboxy33dimethylphenyltriazine.

IUPAC/Chemical Name: (E)-4-(3,3-dimethyltriaz-1-en-1-yl)benzoic acid

InChi Key: GUAZPUYTLMUTMA-ZHACJKMWSA-N

InChi Code: InChI=1S/C9H11N3O2/c1-12(2)11-10-8-5-3-7(4-6-8)9(13)14/h3-6H,1-2H3,(H,13,14)/b11-10+

SMILES Code: O=C(O)C1=CC=C(/N=N/N(C)C)C=C1

Appearance:
Solid powder

Purity:
>98% (or refer to the Certificate of Analysis)

Shipping Condition:
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition:
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility:
Soluble in DMSO, not in water

Shelf Life:
>5 years if stored properly

Drug Formulation:
This drug may be formulated in DMSO

Stock Solution Storage:
0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code:
2934.99.9001

Handling Instructions:
View handling instruction

Preparing Stock Solutions

The following data is based on the product molecular weight 193.2 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Select a batch to recalculate based on the batch molecular weight:
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Bleehen NM, Calvert AH, Lee SM, Harper P, Kaye SB, Judson I, Brampton M. A Cancer Research Campaign (CRC) phase II trial of CB10-277 given by 24 hour infusion for malignant melanoma. Br J Cancer. 1994 Oct;70(4):775-7. PubMed PMID: 7917939; PubMed Central PMCID: PMC2033397.

2: Lee SM, O'Connor PJ, Thatcher N, Crowther D, Margison GP, Cooper DP. Relationships between the formation of O6-methyldeoxyguanosine by 1-p-carboxyl-3,3-dimethylphenyltriazene in DNA and O6-alkylguanine-DNA alkyltransferase in human peripheral leukocytes. Cancer Res. 1994 Aug 1;54(15):4072-6. PubMed PMID: 8033139.

3: Foster BJ, Newell DR, Gumbrell LA, Jenns KE, Calvert AH. Phase I trial with pharmacokinetics of CB10-277 given by 24 hours continuous infusion. Br J Cancer. 1993 Feb;67(2):369-73. PubMed PMID: 8431368; PubMed Central PMCID: PMC1968159.

4: Foster BJ, Newell DR, Carmichael J, Harris AL, Gumbrell LA, Jones M, Goodard PM, Calvert AH. Preclinical, phase I and pharmacokinetic studies with the dimethyl phenyltriazene CB10-277. Br J Cancer. 1993 Feb;67(2):362-8. PubMed PMID: 8431367; PubMed Central PMCID: PMC1968184.

5: Lee SM, Thatcher N, Crowther D, Margison GP. In vivo depletion of O6-alkylguanine-DNA-alkyltransferase in lymphocytes and melanoma of patients treated with CB 10-277, a new DTIC analogue. Cancer Chemother Pharmacol. 1992;31(3):240-6. PubMed PMID: 1464162.

img

CB10-277



Additional Information